JPRN-UMIN000038648已完成未知
Analysis of EGFR mutation using highly sensitive droplet digital PCR in non-small cell lung cancer patients with EGFR mutations. - Analysis of EGFR mutation using highly sensitive droplet digital PCR in non-small cell lung cancer patients with EGFR mutations.
agasaki University Hospital0 个研究点目标入组 5 人开始时间: 2019年11月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients cannot ingest EGFR-TKIs. 2)Patients with paresis of intestine or ileus of intestine. 3)With chronic diarrhea. 4)Interstitial pulmonary disease, drug-induced interstitial pulmonary disease and irradiation pneumonitis clearly detected by chest CT. 5)Uncontrollable pleural/ abdominal/ pericardial effusion. 6)Symptomatic brain metastasis required for radiation therapy or surgical resection. 7)Patients with a radiation therapy included lung field within 28 days before enrollment. 8)Active infection to need systemic treatment. 9)Patients with severe complications (bleeding of digestive tract, heart disease, glaucoma, diabetes, etc.). 10)Patients who are different for the participation in the study by complication of mental disease or psychiatric symptom. 11)Patients with pregnant or possibly pregnant, nursing. 12)Any other patients regarded as unsuitable for this study by the investigators.
研究者
相似试验
已完成
不适用
An obsevational study of EGFR mutation status by circulating tumor DNA and tissue during the osimertinib treatment in poor PS patients with T790M positive advanced NSCLCnon small cell lung cancerJPRN-UMIN000025718orth East Japan Study Group (NEJSG)32
已完成
不适用
Study on the detection of EGFR mutation using the high sensitive PCR method in lung cancerlung cancerJPRN-UMIN000033567Shizuoka Cancer Center50
招募中
不适用
The continuous evaluation of EGFR mutation in EGFR-mutation positive lung cancer patients during EGFR TKI treatmentnon-small cell lung cancerJPRN-UMIN000037232Advanced Cancer Translational Research Institute100
已完成
不适用
An observational study of EGFR mutation status by circulating tumor DNA during the osimertinib treatment of lung cancer harboring EGFR activating and T790M mutations.lung CancerJPRN-UMIN000025278Miyagi Cancer Center60
已完成
不适用
Monitoring EGFR mutation status with cell-free DNA: a prospective exploratory analyses of phase Ib study of osimertinib plus ramucirumab in lung adenocarcinoma patients with EGFR T790M mutatioung CancerJPRN-UMIN000030164Wakayama Medical University3
